Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Motor Imagery in Pain Modulation and Median Nerve Mechanosensitive in Healthy Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04086563
Recruitment Status : Recruiting
First Posted : September 11, 2019
Last Update Posted : September 11, 2019
Sponsor:
Information provided by (Responsible Party):
Josue Fernandez Carnero, Universidad Rey Juan Carlos

Brief Summary:
The aim of this study are 1) to determinate the effectiveness of motor imagery or strength training in differens aspects of pain modulation. 2) evaluate the functional improvement of the hand by a motor imagery protocol.

Condition or disease Intervention/treatment Phase
Median Nerve Injury Other: Action observation Other: Mirror therapy Other: Neurodynamic exercises Other: Strength Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Effects of Motor Imagery in Pain Modulation and Median Nerve Mechanosensitive in Healthy Patients
Estimated Study Start Date : September 8, 2019
Estimated Primary Completion Date : January 31, 2020
Estimated Study Completion Date : February 25, 2020

Arm Intervention/treatment
Experimental: Action observation
The patients will observe a 25 minutes clip of neurodynamic exercises of the hand.
Other: Mirror therapy
With a mirror glasses on, do the neurodynamic exercises with the non-dominant hand while the patient is looking at the dominant hand

Other: Neurodynamic exercises
active movement of the dominant hand. Do neurodynamic exercises.

Other: Strength
Execute a short strength training for the dominant hand

Experimental: Mirror Therapy
With a mirror glasses, the patients will execute neurodynamic movements of their non-dominant hand during 25 minutes.
Other: Action observation
look at a clip of a hand doing neurodynamic exercises.

Other: Neurodynamic exercises
active movement of the dominant hand. Do neurodynamic exercises.

Other: Strength
Execute a short strength training for the dominant hand

Active Comparator: Strength Training
Strength protocol for the dominant hand.
Other: Action observation
look at a clip of a hand doing neurodynamic exercises.

Other: Mirror therapy
With a mirror glasses on, do the neurodynamic exercises with the non-dominant hand while the patient is looking at the dominant hand

Other: Neurodynamic exercises
active movement of the dominant hand. Do neurodynamic exercises.

Experimental: Neurodynamic exercise
Active neurodynamic exercises for the dominant hand.
Other: Action observation
look at a clip of a hand doing neurodynamic exercises.

Other: Mirror therapy
With a mirror glasses on, do the neurodynamic exercises with the non-dominant hand while the patient is looking at the dominant hand

Other: Strength
Execute a short strength training for the dominant hand




Primary Outcome Measures :
  1. Conditioned pain modulation [ Time Frame: Change from baseline at 2 weeks ]
    Diffused noxious inhibitory control system will be measure with tourniquet test

  2. Pressure pain threshold [ Time Frame: Change from baseline at 2 weeks ]
    Three consecutive trials of pressure pain threshold on the active trigger point at a rate of 1 kg/sec at intervals of 30 seconds were conducted.

  3. Cold hyperalgesia [ Time Frame: Change from baseline at 2 weeks ]
    10 seconds of a cold pack and after that, rating the pain from 0 to 10

  4. Neural mechanosensitive [ Time Frame: Change from baseline at 2 weeks ]
    Upper Limb Neurodynamic test 1 (ULNT1)


Secondary Outcome Measures :
  1. Strength_grip [ Time Frame: Change from baseline at 2 weeks ]
    grip strength without pain

  2. Imagine movement capacity [ Time Frame: Change from baseline at 2 weeks ]

    testing the capacity of imagine that their own body is movement. Movement Imagery Questionnaire-Revised (MIQ-R questionaire).

    top score 56 and bottom score 8. The higher values indicates a better outcome.


  3. Psychological factors_Anxiety [ Time Frame: Change from baseline at 2 weeks ]
    State Trait Anxiety Inventory (STAI-T). Top score 60 and bottom score 0. The higher values indicate worst outcomes.

  4. Psychological factors_Depression [ Time Frame: Change from baseline at 2 weeks ]

    Beck Depression Inventory (BDI-II). the scores goes from 0 to 63. The higher values indicate worst outcomes.

    Beck Depression Inventory (BDI-II)

    Beck Depression Inventory (BDI-II)


  5. Psychological factors_Kinesiophobia [ Time Frame: Change from baseline at 2 weeks ]
    Tampa Scale for Kinesiophobia. Total scores goes from 11 to 44.The higher values indicate worst outcomes.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • be under 18
  • any pathology which provoke pain.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04086563


Contacts
Layout table for location contacts
Contact: Josue Fernandez, PhD 34914888949 josue.fernandez@urjc.es
Contact: Luis Matesanz 675042482 l.matesanz.2018@alumnos.urjc.es

Locations
Layout table for location information
Spain
Universidad Rey Juan Carlos Recruiting
Alcorcón, Madrid, Spain, 28922
Contact: Josué Fernández, PhD    34914888949    josue.fernandez@urjc.com   
Contact: Luis M Matesanz    675042482    l.matesanz.2018@alumnos.urjc.es   
Sponsors and Collaborators
Universidad Rey Juan Carlos

Layout table for additonal information
Responsible Party: Josue Fernandez Carnero, Principal Investigator, Universidad Rey Juan Carlos
ClinicalTrials.gov Identifier: NCT04086563     History of Changes
Other Study ID Numbers: 2703201906919
First Posted: September 11, 2019    Key Record Dates
Last Update Posted: September 11, 2019
Last Verified: September 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No